Industry
The solutions will aim to improve the diagnosis of diseases thanks to a more detailed analysis of the intestinal, oral, ocular, cancer or pulmonary microbiomes.
Patrice Cani (Université catholique de Louvain) discusses the future of Akkermansia municiphila.
George Paraskevakos (International Probiotics Association) discusses the challenges on microbiome space.
MaaT Pharma has established a comprehensive approach to restoring the patient-microbiome symbiosis in oncology.
Stephen Daniells (William Reed Business Media Ltd.) discusses what emerged at Probiota Global 2022.
Can a mutual solution be found for probiotics in Europe? Legal analysis, dilemmas, solutions are the topics of the webinar by IPA Europe, 4 April 2022.
The International Probiotics Association and the European Dairy Association are jointly asking to reinforce their involvement in the definition of the current view of probiotic products in Europe
Probiota Global 2022, 28-30 March, is the ideal place to gain the latest knowledge in the field of prebiotics, probiotics and the microbiome.
Axial Therapeutics has published the results of a Clinical Trial investigating a novel molecule for managing symptoms associated with autism.
Probiota 2022: connecting the business and science of the microbiome is back in Copenhagen from the 28th to the 30th March.
